Inactive Instrument
Celladon Corp Stock Nasdaq
Stocks
US15117E1073
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 12.59M 11.18M 10.44M 9.51M 17.94M 1.21B 18.11M 126M 48.95M 619M 47.26M 46.23M 1.99B | P/E 2022 |
-0.51x | P/E 2023 | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 27.95M 24.83M 23.17M 21.12M 39.84M 2.69B 40.21M 280M 109M 1.37B 105M 103M 4.41B | EV / Sales 2022 |
-836,796x | EV / Sales 2023 | 1,605,487x |
| Free-Float |
86.47% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -4.91% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 59 | 2022-04-17 | |
Douglas Staut
PRN | Corporate Officer/Principal | - | 2024-04-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.91% | -10.06% | - | - | 12.59M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 59.26B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.14B | |
| -0.78% | -4.35% | +26.55% | +33.38% | 42.91B | |
| -0.09% | +0.35% | +350.07% | +685.94% | 44.13B | |
| -1.62% | -2.29% | +2.15% | +97.52% | 40.79B | |
| -0.54% | +2.93% | +9.50% | +50.41% | 30.77B | |
| -2.68% | +5.11% | +33.11% | +19.50% | 29.31B | |
| +1.11% | -7.13% | -28.38% | +331.34% | 23.71B | |
| Average | -0.74% | -0.64% | +52.06% | +157.93% | 43.6B | |
| Weighted average by Cap. | +0.01% | -0.40% | +57.18% | +149.62% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 13.48 11.98 11.18 10.19 19.22 1.3K 19.4 135.32 52.44 662.66 50.63 49.53 2.13K | 15.77 14.01 13.08 11.92 22.48 1.52K 22.69 158.29 61.34 775.15 59.22 57.93 2.49K |
| Net income | -96.78M -85.99M -80.25M -73.15M -138M -9.3B -139M -971M -376M -4.76B -363M -355M -15.26B | -74.96M -66.6M -62.16M -56.66M -107M -7.21B -108M -752M -292M -3.68B -281M -275M -11.82B |
| Net Debt | -63.29M -56.23M -52.49M -47.84M -90.22M -6.08B -91.06M -635M -246M -3.11B -238M -232M -9.98B | 15.36M 13.65M 12.74M 11.61M 21.89M 1.48B 22.1M 154M 59.73M 755M 57.67M 56.41M 2.42B |
Employees
-
